)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Intensity Therapeutics (INTS) investor relations material
Intensity Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Focused on late-stage clinical development of INT230-6, a novel intratumoral cancer therapy, with ongoing and paused Phase 2 and 3 trials due to funding constraints; protocol amendment and enrollment restart for INVINCIBLE-4 Study in Q1 2026.
No revenue generated to date; operations funded primarily through equity and convertible note offerings.
Net loss for the nine months ended September 30, 2025 was $8.6 million, with an accumulated deficit of $75.3 million.
Cash and cash equivalents as of September 30, 2025 were $7.1 million, with an additional $6 million raised post-quarter, totaling $13.6 million raised since Q3 2025.
Published IT-01 Study results showing strong disease control and survival in advanced cancers.
Financial highlights
Research and development expenses for the nine months ended September 30, 2025 were $5.3 million, down 38% year-over-year; Q3 2025 R&D expenses were $1.6 million, down from $2.2 million in Q3 2024.
General and administrative expenses for the same period were $3.5 million, down 27% year-over-year; Q3 2025 G&A expenses were $1.2 million, down from $1.4 million in Q3 2024.
Net loss for the nine months ended September 30, 2025 was $8.6 million, an improvement from $13.1 million in the prior year period; Q3 2025 net loss was $2.7 million, compared to $3.5 million in Q3 2024.
Weighted average shares outstanding increased significantly to 43.0 million in Q3 2025 from 13.8 million in Q3 2024 due to equity issuances.
Cash and cash equivalents totaled $7.1 million as of September 30, 2025.
Outlook and guidance
Sufficient cash runway projected through the end of Q1 2027, supporting ongoing and planned clinical activities.
Plans to restart paused clinical trials, including INVINCIBLE-4 in Q1 2026 and INVINCIBLE-3 once funding is secured.
Substantial doubt remains about ability to continue as a going concern without additional capital.
INVINCIBLE-4 dosing change impact on trial
Is INVINCIBLE-3 restart covered by current cash?
INT230-6's unique advantage as local therapy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Intensity Therapeutics earnings date
Q4 202513 Mar, 2026
Next Intensity Therapeutics earnings date
Q4 202513 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Intensity Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of cancer immunotherapies. The company's lead platform is designed to deliver therapeutic agents directly into tumors to stimulate immune activation and systemic anti-cancer effects. Its development activities span preclinical research through clinical trials targeting various solid tumors. Intensity Therapeutics Inc is headquartered in Westport, Connecticut, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage